RM
Ramilaben Mahendrakumar Patel
About Ramilaben Mahendrakumar Patel
Data last updated:
Ramilaben Mahendrakumar Patel is a Director at Lexene Pharma Private Limited (since 2025). The company operates in Pharma. Lexene Pharma Private Limited reported revenue of ₹10.50 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Jul 2025 | 2020 | ₹10.50 Cr (FY 2025) | Active |
Board colleagues of Ramilaben Mahendrakumar Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hiteshbhai Kalidas Patel | 08785913 | Lexene Pharma Private Limited | Director |
| Kinchit Hiteshbhai Patel | 08757073 | Lexene Pharma Private Limited | Director |
| Mahendrakumar Dhanabhai Patel | 08757075 | Lexene Pharma Private Limited | Director |
| Mukeshkumar Bhogilal Patel | 08757074 | Lexene Pharma Private Limited | Director |
| Ramaben Hiteshbhai Patel | 08786783 | Lexene Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramilaben Mahendrakumar Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramilaben Mahendrakumar Patel
Ramilaben Mahendrakumar Patel currently holds 1 directorship: Lexene Pharma Private Limited (Director, since 07 Jul 2025, revenue ₹10.50 Cr (FY 2025)).
Ramilaben Mahendrakumar Patel was first appointed on 07 Jul 2025 as Director at Lexene Pharma Private Limited.
The current boards of Ramilaben Mahendrakumar Patel's companies include Hiteshbhai Kalidas Patel (Lexene Pharma Private Limited), Kinchit Hiteshbhai Patel (Lexene Pharma Private Limited), Mahendrakumar Dhanabhai Patel (Lexene Pharma Private Limited), Mukeshkumar Bhogilal Patel (Lexene Pharma Private Limited), Ramaben Hiteshbhai Patel (Lexene Pharma Private Limited).